Abstract: An intermediate data set can be generated based on an image of a set of objects, where each of the set of objects includes a plastic. A predicted chemometric property can be generated by inputting the intermediate data set to a machine-learning model. The chemometric property can be of a physical output pyrolysis oil produced by performing a pyrolysis processing of the set of objects using a pyrolysis reactor. A result associated with the set of objects can be generated, where the result is based on or includes the predicted chemometric property.

Abstract: A system for sensing material within a container includes a container having a reservoir for storing material and an impact member configured to selectively impart an impulse force on the container to cause vibration of the container. A sensor is configured to sense the vibration of the container upon the impact member imparting the impulse force on the container. Processing circuitry in communication with the sensor is configured to determine an estimate of an amount of the material in the container based on the sensed vibration of the container.

Abstract: A system for an electrophotographic image forming device includes a toner container having a reservoir for storing toner and an impact member configured to selectively impart an impulse force on the toner container to cause vibration of the toner container. A sensor is configured to sense the vibration of the toner container upon the impact member imparting the impulse force on the toner container. Processing circuitry in communication with the sensor is configured to determine an estimate of an amount of toner in the reservoir based on the sensed vibration of the toner container.

Abstract: A system can include one or more processors; memory; a data interface that receives data; a control interface that transmits control signals for control of pumps of a hydraulic fracturing operation; and one or more components that can include one or more of a modeling component that predicts pressure in a well fluidly coupled to at least one of the pumps, a pumping rate adjustment component that generates a pumping rate control signal for transmission via the control interface, a capacity component that estimates a real-time pumping capacity for each individual pump, and a control component that, for a target pumping rate for the pumps during the hydraulic fracturing operation, generates at least one of engine throttle and transmission gear settings for each of the individual pumps using an estimated real-time pumping capacity for each individual pump where the settings are transmissible via the control interface.

Abstract: The present disclosure provides a replication-competent, recombinant oncolytic vaccinia virus (RVV), compositions comprising the RVV, and use of the RVV or composition for inducing oncolysis in an individual having a tumor.

Abstract: The present disclosure provides a replication-competent, recombinant oncolytic vaccinia virus; and compositions comprising the replication-competent, recombinant oncolytic vaccinia virus. The present disclosure also provides use of the vaccinia virus or composition for inducing oncolysis in an individual having a tumor.

Abstract: The present disclosure provides human IL-2 variants, recombinant oncolytic viruses comprising the IL-2 variant, compositions comprising the IL-2 variant or recombinant oncolytic virus, and use of the IL-2 variants, recombinant oncolytic virus, or compositions for treating cancer in an individual.

Abstract: The present disclosure provides a replication-competent, recombinant oncolytic vaccinia virus; and compositions comprising the replication-competent, recombinant oncolytic vaccinia virus. The present disclosure also provides use of the vaccinia virus or composition for inducing oncolysis in an individual having a tumor.

Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.

Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide containing a phosphorylation site (with or without phosphorylation of the site) linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositions thereof and their use in medicine.